Kevzara (Sarilumab) article in todays Daily Mail ... - PMRGCAuk

PMRGCAuk

21,302 members40,389 posts

Kevzara (Sarilumab) article in todays Daily Mail about woman with PMR

Tiggy70 profile image
8 Replies

For anyone interested there’s a full page article in todays Daily Mail about a woman’s experience with PMR/GCA (See above). Sarilumab (Kevzara) is mentioned as possibly being released by NICE for PMR patients next year. I’m not sure how accurate that is.

Written by
Tiggy70 profile image
Tiggy70
To view profiles and participate in discussions please or .
Read more about...
8 Replies
DorsetLady profile image
DorsetLadyPMRGCAuk volunteer

Already posted - twice -

healthunlocked.com/pmrgcauk...

healthunlocked.com/pmrgcauk...

Tiggy70 profile image
Tiggy70 in reply toDorsetLady

Sorry didn’t see those😬

DorsetLady profile image
DorsetLadyPMRGCAuk volunteer in reply toTiggy70

No probs… if HU’s algorithms worked you might have seen related posts….

Grammy80 profile image
Grammy80 in reply toDorsetLady

😅😂😅 Yep, here I am 9 days late looking for the link....thanks🥴💞

PMRpro profile image
PMRproAmbassador

As I explained on one of the other threads - it may be submitted to NICE for consideration next year. It is highly unlikely to be approved then. Officially it takes just under a year

cancerresearchuk.org/about-...

But the most likely decision is strict restriction as was the case with tocilizumab for GCA - in 2018 only a 52 week supply for patients with relapsing biopsy/imaging proven GCA was approved. Six years later that is still the case, despite protestation and an appeal is underway to get it extended - after a self-funded study of the relapse rate after a stopping TCZ after a year.

NICE claimed they could only approve a year as there were no long term safety studies. TCZ has been used in rheumatology since 2012 - with no restrictions on duration of use.

SnazzyD profile image
SnazzyD

I bet it’ll only be for tricky cases or something that will mean it isn’t first line for all since it’ll be very expensive. Similar to GCA and Actemra.

AtopicGuy profile image
AtopicGuy

The article is based on this US-based study from October 2023, which includes Dr Bhaskar Dasgupta as an author:

pubmed.ncbi.nlm.nih.gov/377...

Quite rightly, those not injected with sarilumab were injected with a placebo instead. The study was funded by Sanofi and Regeneron Pharmaceuticals, the makers of sarilumab (brand name Kevzara).

Tiggy70 profile image
Tiggy70

Thanks. As PMR pro says I don’t think it’ll be available for us to try anytime soon.

Not what you're looking for?

You may also like...

Kevzara (sarilumab) to treat PMR

I am 54, diagnosed with PMR June 2022 but symptoms started Nov 2021. I have tapered Pred to 8mg and...
BuddyBearF profile image

Article in today's paper about PMR

Someone called Jo Waters (doesn't say she is a Dr) has put a full page article in the Good Health...
Purplegloss profile image

DAILY MAIL ARTICLE

Hi Everyone, Just wondered if anyone had read the article on Temporal Arteritis yesterday featured...
theresa49 profile image

GCA Article Daily Mail

In the Heath Section of the Daily Mail Tuesday 10th July is a really good article on a new...
Estellemac profile image

Suboptimal prescribing of osteoporosis medications in people with PMR

https://rheumatology.medicinematters.com/bsr-2021/polymyalgia-rheumatica-/suboptimal-prescribing-ost
PMRpro profile image
Ambassador

Moderation team

SophieMB profile image
SophieMBPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.